VSTM

#2924
Verastem, Inc.
5.66 USD
+6.59%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
5.66
5.66
Year Range
4.01
11.25
Daily Change
+6.59%
Monthly Change
+0.89%
6 month change
-38.01%
Year Change
+17.43%
Previous Close
5.31
Open
5.66
Bid
Ask
Low
5.66
High
5.66
Volume
61
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 497.15 M
  • Employee 102
  • Founded 2010
  • CEO Brian Stuglik
  • Website www.verastem.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001J2LSK5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.56
Price to sales ratio
17.31

Verastem Inc

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

News